Effects of resveratrol on bone health in type 2 diabetic patients. A double-blind randomized-controlled trial

Summary of the article: Effects of resveratrol on bone health in type 2 diabetic patients. A double-blind randomized-controlled trial

This research article studies about "Effects of resveratrol (Resveratrol) on bone health in patients with type 2 diabetes," published in the journal Nutrition & Diabetes, was a randomized, double-blind controlled trial. (Double-blind Randomized-controlled Trial)

The main points can be summarized as follows:

1. Objectives of the study

To check whether supplementing with Resveratrol (Resveratrol), which is a phytochemical in the polyphenol group (found mostly in red grape peels and mulberry) can help improve bone mineral density (BMD) and bone formation/resorption markers in people with type 2 diabetes, as these patients are at higher risk of osteoporosis and bone fractures than normal people.

​2. Experimental method

Sample group: 66 patients with type 2 diabetes.

Duration: 12 weeks

Grouping:

Control group: received placebo (Placebo)

​Experimental group: received high dose of Resveratrol (500 mg per day)

​3. Important study results

At the end of 12 weeks, the Resveratrol group had improved compared to the control group as follows:

Increased bone mineral density (BMD): A significant increase in bone mass was observed. Especially in the lumbar spine.

Bone formation indicators: there is an increase in the level Bone-specific alkaline phosphatase (BAP), an enzyme that indicates the process of new bone formation

No Serious Side Effects: Taking Resveratrol In these doses it is safe and well tolerated by patients.

​4. Summary of the researcher

Resveratrol supplementation It is an effective alternative to "Prevent and treat osteoporosis" in patients with type 2 diabetes by stimulating bone formation and increasing bone density. This reduces the risk of future fractures.